microRNA information: hsa-miR-625-3p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-625-3p | miRbase |
| Accession: | MIMAT0004808 | miRbase |
| Precursor name: | hsa-mir-625 | miRbase |
| Precursor accession: | MI0003639 | miRbase |
| Symbol: | MIR625 | HGNC |
| RefSeq ID: | NR_030355 | GenBank |
| Sequence: | GACUAUAGAACUUUCCCCCUCA |
Reported expression in cancers: hsa-miR-625-3p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|---|---|---|---|---|
| hsa-miR-625-3p | breast cancer | downregulation | "Here we show that miR-625 was frequently down-regu ......" | 26806308 | |
| hsa-miR-625-3p | colorectal cancer | upregulation | "High expression of microRNA 625 3p is associated w ......" | 23506979 | |
| hsa-miR-625-3p | colorectal cancer | downregulation | "Decreased expression of microRNA 625 is associated ......" | 23861214 | |
| hsa-miR-625-3p | esophageal cancer | downregulation | "The decreased expression of miR 625 predicts poor ......" | 26309624 | qPCR |
| hsa-miR-625-3p | gastric cancer | downregulation | "Here we report that expression of miR-625 is signi ......" | 22677169 | |
| hsa-miR-625-3p | liver cancer | downregulation | "In this study we found that miR-625 was frequently ......" | 24632613 |
Reported cancer pathway affected by hsa-miR-625-3p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-625-3p | endometrial cancer | cell cycle pathway | "The expression of miRNAs and related genes were de ......" | 23680357 | Western blot; Flow cytometry; Colony formation |
Reported cancer prognosis affected by hsa-miR-625-3p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|---|---|---|---|---|
| hsa-miR-625-3p | breast cancer | staging; worse prognosis | "miR 625 suppresses cell proliferation and migratio ......" | 26806308 | |
| hsa-miR-625-3p | colorectal cancer | drug resistance; staging; recurrence | "High expression of microRNA 625 3p is associated w ......" | 23506979 | |
| hsa-miR-625-3p | colorectal cancer | metastasis; worse prognosis; cell migration; staging; poor survival | "Decreased expression of microRNA 625 is associated ......" | 23861214 | |
| hsa-miR-625-3p | colorectal cancer | cell migration; motility | "MiR 625 3p promotes cell migration and invasion vi ......" | 26314959 | Transwell assay; Wound Healing Assay |
| hsa-miR-625-3p | endometrial cancer | progression; metastasis; tumorigenesis | "The expression of miRNAs and related genes were de ......" | 23680357 | Western blot; Flow cytometry; Colony formation |
| hsa-miR-625-3p | esophageal cancer | worse prognosis; staging; metastasis; differentiation; poor survival; progression | "The decreased expression of miR 625 predicts poor ......" | 26309624 | |
| hsa-miR-625-3p | gastric cancer | metastasis | "Down regulated miR 625 suppresses invasion and met ......" | 22677169 | |
| hsa-miR-625-3p | liver cancer | staging; metastasis; poor survival; cell migration; progression | "miR 625 suppresses tumour migration and invasion b ......" | 24632613 |
Reported gene related to hsa-miR-625-3p
| miRNA | cancer | gene | reporting | PUBMED |
|---|---|---|---|---|
| hsa-miR-625-3p | breast cancer | EGF | "Decrease of miR-625 was closely associated with es ......" | 26806308 |
| hsa-miR-625-3p | breast cancer | ESR1 | "Decrease of miR-625 was closely associated with es ......" | 26806308 |
| hsa-miR-625-3p | breast cancer | HMGA1 | "miR 625 suppresses cell proliferation and migratio ......" | 26806308 |
| hsa-miR-625-3p | liver cancer | IGF2 | "Mechanistically miR-625 was confirmed to downregul ......" | 24632613 |
| hsa-miR-625-3p | liver cancer | IGF2BP1 | "miR 625 suppresses tumour migration and invasion b ......" | 24632613 |
| hsa-miR-625-3p | gastric cancer | ILK | "Down regulated miR 625 suppresses invasion and met ......" | 22677169 |
| hsa-miR-625-3p | colorectal cancer | SCAI | "MiR 625 3p promotes cell migration and invasion vi ......" | 26314959 |
| hsa-miR-625-3p | esophageal cancer | SOX2 | "miR 625 down regulation promotes proliferation and ......" | 24508466 |
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-625-3p | RIMBP2 | 10 cancers: BLCA; ESCA; HNSC; KIRC; KIRP; OV; PAAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.34; TCGA ESCA -0.434; TCGA HNSC -0.276; TCGA KIRC -1.211; TCGA KIRP -1.632; TCGA OV -0.304; TCGA PAAD -1.118; TCGA THCA -0.429; TCGA STAD -0.72; TCGA UCEC -0.656 |
hsa-miR-625-3p | COL4A3BP | 11 cancers: BLCA; CESC; KIRC; LIHC; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.106; TCGA CESC -0.082; TCGA KIRC -0.09; TCGA LIHC -0.106; TCGA LUSC -0.124; TCGA PAAD -0.106; TCGA PRAD -0.165; TCGA SARC -0.134; TCGA THCA -0.192; TCGA STAD -0.065; TCGA UCEC -0.087 |
hsa-miR-625-3p | RUNDC3B | 11 cancers: BLCA; COAD; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.204; TCGA COAD -0.219; TCGA KIRC -0.224; TCGA LIHC -0.559; TCGA LUAD -0.222; TCGA LUSC -0.26; TCGA PAAD -0.395; TCGA PRAD -0.152; TCGA SARC -0.217; TCGA THCA -0.293; TCGA STAD -0.275 |
hsa-miR-625-3p | VLDLR | 12 cancers: BLCA; BRCA; CESC; COAD; ESCA; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.359; TCGA BRCA -0.261; TCGA CESC -0.232; TCGA COAD -0.291; TCGA ESCA -0.589; TCGA LUSC -0.237; TCGA PAAD -0.411; TCGA PRAD -0.267; TCGA SARC -0.371; TCGA THCA -0.369; TCGA STAD -0.647; TCGA UCEC -0.195 |
hsa-miR-625-3p | FNIP1 | 13 cancers: BLCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.072; TCGA CESC -0.147; TCGA COAD -0.059; TCGA HNSC -0.06; TCGA KIRP -0.064; TCGA LIHC -0.167; TCGA LUAD -0.068; TCGA LUSC -0.078; TCGA PAAD -0.129; TCGA PRAD -0.075; TCGA SARC -0.176; TCGA THCA -0.092; TCGA UCEC -0.072 |
hsa-miR-625-3p | ZC3H6 | 13 cancers: BLCA; CESC; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.158; TCGA CESC -0.129; TCGA COAD -0.147; TCGA ESCA -0.117; TCGA KIRC -0.092; TCGA LIHC -0.105; TCGA LUAD -0.109; TCGA LUSC -0.11; TCGA PAAD -0.16; TCGA PRAD -0.073; TCGA SARC -0.151; TCGA STAD -0.283; TCGA UCEC -0.205 |
hsa-miR-625-3p | LANCL1 | 11 cancers: BLCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.068; TCGA ESCA -0.098; TCGA HNSC -0.093; TCGA KIRC -0.217; TCGA KIRP -0.215; TCGA LIHC -0.114; TCGA LUAD -0.063; TCGA PRAD -0.148; TCGA SARC -0.245; TCGA STAD -0.102; TCGA UCEC -0.108 |
hsa-miR-625-3p | ETV1 | 9 cancers: BLCA; CESC; ESCA; LGG; LUSC; OV; PAAD; STAD; UCEC | MirTarget | TCGA BLCA -0.222; TCGA CESC -0.222; TCGA ESCA -0.183; TCGA LGG -0.348; TCGA LUSC -0.299; TCGA OV -0.277; TCGA PAAD -0.186; TCGA STAD -0.45; TCGA UCEC -0.257 |
hsa-miR-625-3p | CPEB4 | 16 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.238; TCGA CESC -0.223; TCGA HNSC -0.182; TCGA KIRC -0.344; TCGA KIRP -0.333; TCGA LGG -0.064; TCGA LIHC -0.234; TCGA LUAD -0.133; TCGA LUSC -0.176; TCGA OV -0.071; TCGA PAAD -0.177; TCGA PRAD -0.188; TCGA SARC -0.354; TCGA THCA -0.175; TCGA STAD -0.132; TCGA UCEC -0.204 |
hsa-miR-625-3p | NIPSNAP3B | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.17; TCGA BRCA -0.167; TCGA CESC -0.212; TCGA COAD -0.318; TCGA ESCA -0.239; TCGA KIRC -0.146; TCGA KIRP -0.159; TCGA LIHC -0.09; TCGA LUAD -0.095; TCGA LUSC -0.132; TCGA PAAD -0.299; TCGA SARC -0.482; TCGA THCA -0.098; TCGA UCEC -0.196 |
hsa-miR-625-3p | NEBL | 11 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.186; TCGA COAD -0.15; TCGA HNSC -0.207; TCGA KIRC -0.75; TCGA KIRP -0.268; TCGA LUAD -0.2; TCGA LUSC -0.182; TCGA PRAD -0.315; TCGA THCA -0.165; TCGA STAD -0.338; TCGA UCEC -0.227 |
hsa-miR-625-3p | DGKB | 10 cancers: BLCA; ESCA; KIRC; KIRP; LGG; LUAD; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.714; TCGA ESCA -0.788; TCGA KIRC -0.74; TCGA KIRP -0.648; TCGA LGG -0.24; TCGA LUAD -0.252; TCGA PAAD -0.412; TCGA SARC -0.285; TCGA STAD -1.02; TCGA UCEC -0.37 |
hsa-miR-625-3p | KIAA2022 | 13 cancers: BLCA; CESC; COAD; ESCA; KIRC; KIRP; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.454; TCGA CESC -0.439; TCGA COAD -0.703; TCGA ESCA -0.719; TCGA KIRC -1.173; TCGA KIRP -1.472; TCGA OV -0.209; TCGA PAAD -0.752; TCGA PRAD -0.37; TCGA SARC -1.149; TCGA THCA -0.384; TCGA STAD -1.052; TCGA UCEC -0.428 |
hsa-miR-625-3p | EVI5 | 9 cancers: BLCA; CESC; HNSC; KIRC; KIRP; LIHC; LUSC; PRAD; UCEC | mirMAP | TCGA BLCA -0.059; TCGA CESC -0.072; TCGA HNSC -0.121; TCGA KIRC -0.069; TCGA KIRP -0.145; TCGA LIHC -0.076; TCGA LUSC -0.103; TCGA PRAD -0.161; TCGA UCEC -0.1 |
hsa-miR-625-3p | ZFHX4 | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; OV; PAAD; STAD; UCEC | mirMAP | TCGA BLCA -0.349; TCGA CESC -0.619; TCGA COAD -0.608; TCGA ESCA -0.703; TCGA HNSC -0.223; TCGA LIHC -0.176; TCGA OV -0.205; TCGA PAAD -0.377; TCGA STAD -0.721; TCGA UCEC -0.222 |
hsa-miR-625-3p | MTMR9 | 9 cancers: BLCA; KIRC; KIRP; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.111; TCGA KIRC -0.164; TCGA KIRP -0.106; TCGA LUSC -0.116; TCGA PAAD -0.111; TCGA PRAD -0.196; TCGA SARC -0.149; TCGA STAD -0.243; TCGA UCEC -0.052 |
hsa-miR-625-3p | MEGF9 | 14 cancers: BLCA; CESC; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.103; TCGA CESC -0.124; TCGA ESCA -0.298; TCGA KIRC -0.358; TCGA KIRP -0.227; TCGA LIHC -0.114; TCGA LUAD -0.105; TCGA LUSC -0.203; TCGA OV -0.095; TCGA PAAD -0.151; TCGA PRAD -0.119; TCGA THCA -0.137; TCGA STAD -0.156; TCGA UCEC -0.186 |
hsa-miR-625-3p | TRIM2 | 10 cancers: BLCA; BRCA; KIRC; KIRP; LIHC; OV; PRAD; SARC; THCA; UCEC | mirMAP | TCGA BLCA -0.171; TCGA BRCA -0.325; TCGA KIRC -0.803; TCGA KIRP -0.331; TCGA LIHC -0.115; TCGA OV -0.163; TCGA PRAD -0.331; TCGA SARC -0.141; TCGA THCA -0.216; TCGA UCEC -0.245 |
hsa-miR-625-3p | SMAD9 | 13 cancers: BLCA; CESC; COAD; ESCA; KIRC; LGG; LUAD; LUSC; OV; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.275; TCGA CESC -0.296; TCGA COAD -0.26; TCGA ESCA -0.265; TCGA KIRC -0.257; TCGA LGG -0.293; TCGA LUAD -0.252; TCGA LUSC -0.336; TCGA OV -0.249; TCGA PRAD -0.476; TCGA SARC -0.348; TCGA STAD -0.771; TCGA UCEC -0.332 |
hsa-miR-625-3p | IKZF4 | 11 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.082; TCGA COAD -0.094; TCGA ESCA -0.068; TCGA KIRC -0.083; TCGA KIRP -0.101; TCGA LUSC -0.093; TCGA PAAD -0.262; TCGA PRAD -0.075; TCGA SARC -0.122; TCGA STAD -0.213; TCGA UCEC -0.117 |
hsa-miR-625-3p | PLA2G12A | 10 cancers: BLCA; HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.089; TCGA HNSC -0.127; TCGA KIRC -0.225; TCGA KIRP -0.11; TCGA LIHC -0.135; TCGA LUAD -0.093; TCGA PRAD -0.129; TCGA SARC -0.165; TCGA THCA -0.181; TCGA STAD -0.104 |
hsa-miR-625-3p | TMOD2 | 12 cancers: BLCA; BRCA; CESC; COAD; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; STAD; UCEC | mirMAP | TCGA BLCA -0.136; TCGA BRCA -0.229; TCGA CESC -0.233; TCGA COAD -0.22; TCGA KIRC -0.124; TCGA KIRP -0.393; TCGA LUAD -0.102; TCGA LUSC -0.342; TCGA PAAD -0.343; TCGA PRAD -0.111; TCGA STAD -0.417; TCGA UCEC -0.276 |
hsa-miR-625-3p | DSTYK | 16 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.066; TCGA BRCA -0.135; TCGA CESC -0.175; TCGA COAD -0.13; TCGA ESCA -0.196; TCGA HNSC -0.098; TCGA KIRC -0.248; TCGA KIRP -0.197; TCGA LUAD -0.087; TCGA LUSC -0.117; TCGA PAAD -0.233; TCGA PRAD -0.09; TCGA SARC -0.14; TCGA THCA -0.082; TCGA STAD -0.252; TCGA UCEC -0.158 |
hsa-miR-625-3p | IL6ST | 9 cancers: BLCA; COAD; KIRC; KIRP; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.187; TCGA COAD -0.138; TCGA KIRC -0.272; TCGA KIRP -0.716; TCGA LUSC -0.242; TCGA PRAD -0.634; TCGA SARC -0.215; TCGA STAD -0.23; TCGA UCEC -0.465 |
hsa-miR-625-3p | PNPLA8 | 12 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; OV; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.067; TCGA COAD -0.053; TCGA ESCA -0.071; TCGA HNSC -0.231; TCGA KIRC -0.193; TCGA KIRP -0.153; TCGA LGG -0.054; TCGA OV -0.056; TCGA PRAD -0.135; TCGA SARC -0.064; TCGA STAD -0.137; TCGA UCEC -0.081 |
hsa-miR-625-3p | NTRK3 | 11 cancers: BLCA; COAD; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.425; TCGA COAD -0.633; TCGA KIRC -0.603; TCGA KIRP -0.455; TCGA LGG -0.113; TCGA LUAD -0.222; TCGA LUSC -0.436; TCGA PRAD -0.438; TCGA SARC -0.4; TCGA STAD -0.702; TCGA UCEC -0.422 |
hsa-miR-625-3p | ZFHX3 | 10 cancers: BLCA; COAD; HNSC; KIRC; KIRP; LIHC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.139; TCGA COAD -0.199; TCGA HNSC -0.162; TCGA KIRC -0.14; TCGA KIRP -0.153; TCGA LIHC -0.072; TCGA PRAD -0.225; TCGA SARC -0.161; TCGA STAD -0.325; TCGA UCEC -0.074 |
hsa-miR-625-3p | PHLDB2 | 13 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.232; TCGA COAD -0.251; TCGA ESCA -0.68; TCGA HNSC -0.389; TCGA KIRC -0.238; TCGA KIRP -0.099; TCGA LUAD -0.137; TCGA OV -0.224; TCGA PAAD -0.382; TCGA PRAD -0.326; TCGA SARC -0.235; TCGA STAD -0.55; TCGA UCEC -0.466 |
hsa-miR-625-3p | MR1 | 9 cancers: BLCA; COAD; ESCA; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.093; TCGA COAD -0.113; TCGA ESCA -0.282; TCGA LUSC -0.11; TCGA PRAD -0.177; TCGA SARC -0.096; TCGA THCA -0.109; TCGA STAD -0.127; TCGA UCEC -0.195 |
hsa-miR-625-3p | NCAM2 | 9 cancers: BLCA; CESC; COAD; ESCA; LGG; LUSC; OV; PAAD; STAD | mirMAP | TCGA BLCA -0.406; TCGA CESC -0.395; TCGA COAD -0.644; TCGA ESCA -0.874; TCGA LGG -0.087; TCGA LUSC -0.286; TCGA OV -0.321; TCGA PAAD -0.547; TCGA STAD -0.632 |
hsa-miR-625-3p | KCNB1 | 11 cancers: BLCA; BRCA; COAD; ESCA; LGG; LIHC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.669; TCGA BRCA -0.339; TCGA COAD -0.62; TCGA ESCA -0.621; TCGA LGG -0.207; TCGA LIHC -0.304; TCGA PAAD -0.835; TCGA PRAD -0.712; TCGA SARC -0.725; TCGA STAD -1.476; TCGA UCEC -0.529 |
hsa-miR-625-3p | ZYG11B | 12 cancers: BLCA; CESC; ESCA; KIRC; KIRP; LIHC; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.066; TCGA CESC -0.064; TCGA ESCA -0.063; TCGA KIRC -0.195; TCGA KIRP -0.147; TCGA LIHC -0.17; TCGA PAAD -0.093; TCGA PRAD -0.189; TCGA SARC -0.099; TCGA THCA -0.076; TCGA STAD -0.223; TCGA UCEC -0.077 |
hsa-miR-625-3p | GPR155 | 9 cancers: BLCA; COAD; ESCA; KIRC; KIRP; LIHC; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.126; TCGA COAD -0.293; TCGA ESCA -0.222; TCGA KIRC -0.277; TCGA KIRP -0.4; TCGA LIHC -0.156; TCGA PRAD -0.131; TCGA SARC -0.106; TCGA STAD -0.376 |
hsa-miR-625-3p | AMOTL1 | 14 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.237; TCGA CESC -0.175; TCGA COAD -0.398; TCGA ESCA -0.489; TCGA HNSC -0.33; TCGA KIRC -0.106; TCGA LGG -0.125; TCGA LUSC -0.192; TCGA OV -0.163; TCGA PAAD -0.234; TCGA PRAD -0.248; TCGA SARC -0.223; TCGA STAD -0.649; TCGA UCEC -0.183 |
hsa-miR-625-3p | TUB | 15 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.309; TCGA BRCA -0.399; TCGA COAD -0.496; TCGA ESCA -0.814; TCGA KIRC -0.69; TCGA LGG -0.244; TCGA LUAD -0.192; TCGA LUSC -0.236; TCGA OV -0.158; TCGA PAAD -0.594; TCGA PRAD -0.203; TCGA SARC -0.767; TCGA THCA -0.228; TCGA STAD -0.737; TCGA UCEC -0.166 |
hsa-miR-625-3p | SAMD14 | 9 cancers: BLCA; COAD; LGG; LUSC; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.133; TCGA COAD -0.292; TCGA LGG -0.134; TCGA LUSC -0.227; TCGA PRAD -0.184; TCGA SARC -0.203; TCGA THCA -0.126; TCGA STAD -0.169; TCGA UCEC -0.154 |
hsa-miR-625-3p | SGCD | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.69; TCGA BRCA -0.145; TCGA CESC -0.419; TCGA COAD -0.562; TCGA ESCA -0.466; TCGA HNSC -0.346; TCGA LUAD -0.224; TCGA LUSC -0.525; TCGA OV -0.235; TCGA PAAD -0.395; TCGA PRAD -0.281; TCGA SARC -0.361; TCGA STAD -0.613; TCGA UCEC -0.497 |
hsa-miR-625-3p | KCNK3 | 14 cancers: BLCA; BRCA; COAD; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.438; TCGA BRCA -0.362; TCGA COAD -0.459; TCGA KIRP -0.469; TCGA LGG -0.36; TCGA LUAD -0.264; TCGA LUSC -0.361; TCGA OV -0.334; TCGA PAAD -0.655; TCGA PRAD -0.978; TCGA SARC -0.874; TCGA THCA -0.318; TCGA STAD -0.997; TCGA UCEC -0.198 |
hsa-miR-625-3p | PDE7B | 12 cancers: BLCA; CESC; COAD; KIRC; KIRP; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.236; TCGA CESC -0.204; TCGA COAD -0.31; TCGA KIRC -0.593; TCGA KIRP -0.296; TCGA LUSC -0.301; TCGA OV -0.178; TCGA PAAD -0.228; TCGA PRAD -0.262; TCGA THCA -0.52; TCGA STAD -0.576; TCGA UCEC -0.272 |
hsa-miR-625-3p | ANO5 | 9 cancers: BLCA; COAD; KIRC; KIRP; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.503; TCGA COAD -0.513; TCGA KIRC -0.779; TCGA KIRP -0.212; TCGA LUSC -0.346; TCGA PRAD -0.654; TCGA SARC -0.824; TCGA STAD -0.738; TCGA UCEC -0.182 |
hsa-miR-625-3p | THAP2 | 14 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.085; TCGA BRCA -0.106; TCGA CESC -0.144; TCGA COAD -0.109; TCGA ESCA -0.19; TCGA KIRC -0.073; TCGA LGG -0.118; TCGA LUAD -0.114; TCGA LUSC -0.161; TCGA PAAD -0.198; TCGA PRAD -0.064; TCGA SARC -0.13; TCGA STAD -0.216; TCGA UCEC -0.144 |
hsa-miR-625-3p | SH3PXD2B | 13 cancers: BLCA; BRCA; CESC; COAD; ESCA; HNSC; LUSC; OV; PAAD; PRAD; THCA; STAD; UCEC | mirMAP | TCGA BLCA -0.148; TCGA BRCA -0.092; TCGA CESC -0.165; TCGA COAD -0.177; TCGA ESCA -0.323; TCGA HNSC -0.208; TCGA LUSC -0.089; TCGA OV -0.11; TCGA PAAD -0.199; TCGA PRAD -0.311; TCGA THCA -0.094; TCGA STAD -0.321; TCGA UCEC -0.163 |
hsa-miR-625-3p | FAM26E | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LUSC; STAD; UCEC | mirMAP | TCGA BLCA -0.145; TCGA COAD -0.34; TCGA ESCA -0.187; TCGA HNSC -0.167; TCGA KIRC -0.209; TCGA KIRP -0.782; TCGA LUSC -0.319; TCGA STAD -0.257; TCGA UCEC -0.168 |
hsa-miR-625-3p | ZNF677 | 9 cancers: BLCA; CESC; COAD; KIRC; KIRP; LGG; LUSC; PAAD; STAD | mirMAP | TCGA BLCA -0.377; TCGA CESC -0.324; TCGA COAD -0.459; TCGA KIRC -0.554; TCGA KIRP -0.309; TCGA LGG -0.057; TCGA LUSC -0.244; TCGA PAAD -0.257; TCGA STAD -0.518 |
hsa-miR-625-3p | BMPR2 | 13 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LUSC; OV; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.159; TCGA COAD -0.215; TCGA ESCA -0.108; TCGA HNSC -0.092; TCGA KIRC -0.12; TCGA KIRP -0.193; TCGA LGG -0.068; TCGA LUSC -0.201; TCGA OV -0.098; TCGA PRAD -0.213; TCGA SARC -0.165; TCGA STAD -0.196; TCGA UCEC -0.145 |
hsa-miR-625-3p | TMEM170B | 11 cancers: BLCA; BRCA; COAD; KIRC; KIRP; LGG; LIHC; LUAD; PAAD; PRAD; STAD | mirMAP | TCGA BLCA -0.113; TCGA BRCA -0.111; TCGA COAD -0.421; TCGA KIRC -0.141; TCGA KIRP -0.159; TCGA LGG -0.086; TCGA LIHC -0.274; TCGA LUAD -0.143; TCGA PAAD -0.209; TCGA PRAD -0.072; TCGA STAD -0.402 |
hsa-miR-625-3p | TMEM56 | 9 cancers: BRCA; KIRC; LIHC; LUAD; PRAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.339; TCGA KIRC -0.253; TCGA LIHC -0.365; TCGA LUAD -0.117; TCGA PRAD -0.31; TCGA SARC -0.473; TCGA THCA -0.359; TCGA STAD -0.212; TCGA UCEC -0.092 |
hsa-miR-625-3p | ETV3 | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; OV; PRAD; SARC; UCEC | mirMAP | TCGA BRCA -0.115; TCGA CESC -0.232; TCGA ESCA -0.142; TCGA HNSC -0.209; TCGA KIRC -0.241; TCGA KIRP -0.508; TCGA OV -0.085; TCGA PRAD -0.387; TCGA SARC -0.178; TCGA UCEC -0.326 |
hsa-miR-625-3p | ABL2 | 12 cancers: BRCA; CESC; COAD; ESCA; HNSC; LGG; LUAD; LUSC; OV; PAAD; STAD; UCEC | mirMAP | TCGA BRCA -0.129; TCGA CESC -0.077; TCGA COAD -0.149; TCGA ESCA -0.183; TCGA HNSC -0.111; TCGA LGG -0.117; TCGA LUAD -0.075; TCGA LUSC -0.099; TCGA OV -0.099; TCGA PAAD -0.147; TCGA STAD -0.125; TCGA UCEC -0.126 |
hsa-miR-625-3p | GATAD2B | 15 cancers: BRCA; CESC; ESCA; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.14; TCGA CESC -0.144; TCGA ESCA -0.073; TCGA KIRC -0.104; TCGA KIRP -0.153; TCGA LGG -0.077; TCGA LIHC -0.087; TCGA LUAD -0.101; TCGA LUSC -0.053; TCGA OV -0.08; TCGA PAAD -0.079; TCGA PRAD -0.073; TCGA SARC -0.211; TCGA STAD -0.162; TCGA UCEC -0.168 |
hsa-miR-625-3p | STOX2 | 11 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LUAD; OV; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.194; TCGA COAD -0.393; TCGA ESCA -0.522; TCGA HNSC -0.272; TCGA KIRC -0.137; TCGA LUAD -0.14; TCGA OV -0.133; TCGA PRAD -0.688; TCGA SARC -0.587; TCGA STAD -0.527; TCGA UCEC -0.364 |
hsa-miR-625-3p | ATXN1L | 10 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LIHC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BRCA -0.054; TCGA COAD -0.08; TCGA ESCA -0.068; TCGA HNSC -0.137; TCGA KIRC -0.212; TCGA LIHC -0.062; TCGA PRAD -0.174; TCGA SARC -0.076; TCGA STAD -0.114; TCGA UCEC -0.136 |
hsa-miR-625-3p | FAM151B | 9 cancers: CESC; ESCA; KIRC; KIRP; LUAD; LUSC; PAAD; THCA; STAD | MirTarget | TCGA CESC -0.153; TCGA ESCA -0.131; TCGA KIRC -0.082; TCGA KIRP -0.089; TCGA LUAD -0.13; TCGA LUSC -0.179; TCGA PAAD -0.202; TCGA THCA -0.127; TCGA STAD -0.065 |
hsa-miR-625-3p | EXOC8 | 9 cancers: CESC; HNSC; KIRC; KIRP; LIHC; LUAD; PRAD; SARC; UCEC | MirTarget | TCGA CESC -0.104; TCGA HNSC -0.109; TCGA KIRC -0.052; TCGA KIRP -0.124; TCGA LIHC -0.133; TCGA LUAD -0.089; TCGA PRAD -0.081; TCGA SARC -0.063; TCGA UCEC -0.127 |
hsa-miR-625-3p | SNX13 | 12 cancers: CESC; COAD; HNSC; KIRC; KIRP; LIHC; OV; PRAD; SARC; THCA; STAD; UCEC | mirMAP | TCGA CESC -0.078; TCGA COAD -0.081; TCGA HNSC -0.093; TCGA KIRC -0.15; TCGA KIRP -0.114; TCGA LIHC -0.084; TCGA OV -0.071; TCGA PRAD -0.13; TCGA SARC -0.089; TCGA THCA -0.117; TCGA STAD -0.084; TCGA UCEC -0.071 |
hsa-miR-625-3p | PRTG | 11 cancers: CESC; COAD; KIRC; KIRP; LGG; LUAD; LUSC; OV; THCA; STAD; UCEC | mirMAP | TCGA CESC -0.277; TCGA COAD -0.467; TCGA KIRC -0.717; TCGA KIRP -0.541; TCGA LGG -0.285; TCGA LUAD -0.236; TCGA LUSC -0.437; TCGA OV -0.361; TCGA THCA -0.241; TCGA STAD -0.487; TCGA UCEC -0.425 |
hsa-miR-625-3p | ATRNL1 | 9 cancers: COAD; KIRC; KIRP; LGG; OV; PAAD; PRAD; STAD; UCEC | MirTarget | TCGA COAD -0.628; TCGA KIRC -0.635; TCGA KIRP -0.374; TCGA LGG -0.138; TCGA OV -0.343; TCGA PAAD -0.886; TCGA PRAD -0.541; TCGA STAD -0.643; TCGA UCEC -0.485 |
hsa-miR-625-3p | GSTM3 | 9 cancers: COAD; KIRC; KIRP; LUAD; OV; PRAD; SARC; THCA; STAD | mirMAP | TCGA COAD -0.252; TCGA KIRC -0.81; TCGA KIRP -0.671; TCGA LUAD -0.143; TCGA OV -0.284; TCGA PRAD -0.194; TCGA SARC -0.226; TCGA THCA -0.325; TCGA STAD -0.226 |
hsa-miR-625-3p | CDH13 | 11 cancers: COAD; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PRAD; THCA; STAD; UCEC | mirMAP | TCGA COAD -0.201; TCGA ESCA -0.411; TCGA HNSC -0.37; TCGA KIRP -0.653; TCGA LGG -0.098; TCGA LUAD -0.211; TCGA LUSC -0.355; TCGA PRAD -0.149; TCGA THCA -0.439; TCGA STAD -0.213; TCGA UCEC -0.475 |
hsa-miR-625-3p | TGOLN2 | 9 cancers: COAD; KIRC; KIRP; LIHC; LUSC; OV; PRAD; THCA; UCEC | mirMAP | TCGA COAD -0.131; TCGA KIRC -0.129; TCGA KIRP -0.249; TCGA LIHC -0.122; TCGA LUSC -0.132; TCGA OV -0.06; TCGA PRAD -0.182; TCGA THCA -0.065; TCGA UCEC -0.095 |
hsa-miR-625-3p | COG2 | 9 cancers: KIRC; LGG; LIHC; LUAD; OV; PRAD; SARC; THCA; UCEC | MirTarget | TCGA KIRC -0.08; TCGA LGG -0.153; TCGA LIHC -0.067; TCGA LUAD -0.071; TCGA OV -0.051; TCGA PRAD -0.09; TCGA SARC -0.055; TCGA THCA -0.107; TCGA UCEC -0.085 |
Enriched cancer pathways of putative targets